Oct 26 (Reuters) - Antisense Therapeutics Ltd ANP.AX :
* US FDA OFFICE OF ORPHAN PRODUCTS DEVELOPMENT GRANTED ORPHAN DRUG DESIGNATION TO ATL1102
Oct 26 (Reuters) - Antisense Therapeutics Ltd ANP.AX :
* US FDA OFFICE OF ORPHAN PRODUCTS DEVELOPMENT GRANTED ORPHAN DRUG DESIGNATION TO ATL1102